Kiwa Bio-Tech Products Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Kiwa Bio-Tech Products Group generated cash of $183,067, which is more than the previous year. Cash used in financing activities reached the amount of $1,482,086 last year. Net change in cash is therefore $106.
Cash Flow
| 2012 | -242.70K | 0 | 236.41K |
|---|---|---|---|
| 2013 | -138.02K | 0 | 124.08K |
| 2014 | -143.25K | 0 | 144.19K |
| 2015 | -150.20K | 0 | 148.00K |
| 2016 | -1.14M | -79.08K | 1.05M |
| 2017 | -5.64M | -815.12K | 7.53M |
| 2018 | -1.64M | -52.99K | 559.77K |
| 2019 | 183.06K | -2.07M | 1.48M |
KWBT Cash Flow Statement (2012 – 2019)
| 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 7.85K | 1.08M | 13.46K | 721 | 2.96K | 2.03K | 4.49K | 16.30K |
Operating activities | ||||||||
Net income | -6.63M | 343.82K | 813.70K | 963.29K | -677.35K | -617.55K | 3.71M | -1.34M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 47.95K | 27.94K | 46.49K | 23.98K | 4.35K | 4.40K | 4.45K | 4.70K |
Stock-based compensation expense | 1.85M | 2.20M | 697.67K | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 1.85M | 2.20M | 697.67K | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 3.40M | -6.98M | 1.12M | -1.22M | 0 | 0 | 0 | 0 |
Inventories | 1.60M | 994.48K | -2.64M | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -1.46M | -97.10K | 631.32K | 1.33M | 178.98K | 0 | 0 | 0 |
Cash generated by operating activities | 183.06K | -1.64M | -5.64M | -1.14M | -150.20K | -143.25K | -138.02K | -242.70K |
Investing activities | ||||||||
Purchases Of Investments | 0 | 0 | -739.84K | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -52.99K | -75.28K | -79.08K | 0 | 0 | 0 | 0 |
Acquisitions Net | -349 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -2.07M | -52.99K | -815.12K | -79.08K | 0 | 0 | 0 | 0 |
Financing activities | ||||||||
Common Stock Issued | 176K | 307.6K | 6.34M | 914.27K | 1M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | -75K | 0 |
Cash used in financing activities | 1.48M | 559.77K | 7.53M | 1.05M | 148.00K | 144.19K | 124.08K | 236.41K |
Net Change In Cash | 106 | -1.07M | 1.07M | 12.74K | -2.24K | 924 | -2.45K | -11.81K |
Cash at end of period | 7.96K | 7.85K | 1.08M | 13.46K | 721 | 2.96K | 2.03K | 4.49K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |